These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23677575)

  • 1. The clinical and economic burden of a sustained increase in thyroid cancer incidence.
    Aschebrook-Kilfoy B; Schechter RB; Shih YC; Kaplan EL; Chiu BC; Angelos P; Grogan RH
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1252-9. PubMed ID: 23677575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.
    Chen AY; Jemal A; Ward EM
    Cancer; 2009 Aug; 115(16):3801-7. PubMed ID: 19598221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective.
    Lang BH; Wong CK; Chan CT
    Eur J Surg Oncol; 2015 Jun; 41(6):758-65. PubMed ID: 25680952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual financial impact of well-differentiated thyroid cancer care in the United States.
    Lubitz CC; Kong CY; McMahon PM; Daniels GH; Chen Y; Economopoulos KP; Gazelle GS; Weinstein MC
    Cancer; 2014 May; 120(9):1345-52. PubMed ID: 24481684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.
    Owusu-Edusei K; Tejani MN; Gift TL; Kent CK; Tao G
    Sex Transm Dis; 2009 Jun; 36(6):395-9. PubMed ID: 19556934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing thyroid cancer incidence in Lithuania in 1978-2003.
    Smailyte G; Miseikyte-Kaubriene E; Kurtinaitis J
    BMC Cancer; 2006 Dec; 6():284. PubMed ID: 17156468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of illness associated with hepatocellular carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Shah S; Thompson D
    J Hepatol; 2009 Jan; 50(1):89-99. PubMed ID: 18977551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot test for linking population-based cancer registries with CCG/POG pediatric registries.
    Ross F
    J Ky Med Assoc; 2002 May; 100(5):195-9. PubMed ID: 12040910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
    Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
    Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020.
    Yabroff KR; Mariotto AB; Feuer E; Brown ML
    Health Econ; 2008 Aug; 17(8):947-59. PubMed ID: 17910108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future of cancer incidence in the United States: burdens upon an aging, changing nation.
    Smith BD; Smith GL; Hurria A; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2009 Jun; 27(17):2758-65. PubMed ID: 19403886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in breast cancer incidence--United States, 1999-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jun; 56(22):549-53. PubMed ID: 17557070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R; Ramsey SD; Berry K; Brown M
    Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2005 Mar; 90(2):127-37. PubMed ID: 15803359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
    Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney cancer.
    Wallen EM; Pruthi RS; Joyce GF; Wise M;
    J Urol; 2007 Jun; 177(6):2006-18; discussion 2018-9. PubMed ID: 17509280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor vehicle safety, health care, and taxes. National Highway Traffic Safety Administration, U.S. Department of Transportation.
    Prehosp Disaster Med; 1994; 9(1):11-23. PubMed ID: 10155483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.